KRT88P and Hepatitis: In this regard, a Japanese study conducted on 77 patients with lymphoma and signs of resolved hepatitis shows that the combination of anti-HBc and anti-HBs levels may be useful for predicting the development and timing of chemotherapy-induced hepatitis [15].